Skip to main content
SpringerLink
Log in

Guidance on metastatic colorectal cancer, breast cancer issued in the UK

  • Guideline
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. National Institute for Health and Clinical Excellence.Gemcitabine for the treatment of metastatic breast cancer. Technology Appraisal Guidance: 1-24, No. 116, Jan 2007. Available from: URL: http://www.nice.org.uk

  2. National Institute for Health and Clinical Excellence.Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. Technology Appraisal Guidance: 1-34, No. 118, Jan 2007. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guidance on metastatic colorectal cancer, breast cancer issued in the UK. Pharmacoecon. Outcomes News 521, 3 (2007). https://doi.org/10.2165/00151234-200705210-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705210-00008

Keywords

Search

Navigation